These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23800692)

  • 1. Intrinsically fluorescent silica nanocontainers: a promising theranostic platform.
    Rodrigues AS; Ribeiro T; Fernandes F; Farinha JP; Baleizão C
    Microsc Microanal; 2013 Oct; 19(5):1216-21. PubMed ID: 23800692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery.
    Chen Y; Chen H; Zeng D; Tian Y; Chen F; Feng J; Shi J
    ACS Nano; 2010 Oct; 4(10):6001-13. PubMed ID: 20815402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
    Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
    Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatible zwitterionic sulfobetaine copolymer-coated mesoporous silica nanoparticles for temperature-responsive drug release.
    Sun JT; Yu ZQ; Hong CY; Pan CY
    Macromol Rapid Commun; 2012 May; 33(9):811-8. PubMed ID: 22488562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
    Lee JE; Lee N; Kim T; Kim J; Hyeon T
    Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescent hollow/rattle-type mesoporous Au@SiO2 nanocapsules for drug delivery and fluorescence imaging of cancer cells.
    Wang TT; Chai F; Wang CG; Li L; Liu HY; Zhang LY; Su ZM; Liao Y
    J Colloid Interface Sci; 2011 Jun; 358(1):109-15. PubMed ID: 21453927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
    Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel drug delivery system of hollow mesoporous silica nanocapsules with thin shells: preparation and fluorescein isothiocyanate (FITC) release kinetics.
    Liu Y; Miyoshi H; Nakamura M
    Colloids Surf B Biointerfaces; 2007 Aug; 58(2):180-7. PubMed ID: 17420116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sub-150 nm mesoporous silica nanoparticles with tunable pore sizes and well-ordered mesostructure for protein encapsulation.
    Gu J; Huang K; Zhu X; Li Y; Wei J; Zhao W; Liu C; Shi J
    J Colloid Interface Sci; 2013 Oct; 407():236-42. PubMed ID: 23866201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.
    Quan G; Pan X; Wang Z; Wu Q; Li G; Dian L; Chen B; Wu C
    J Nanobiotechnology; 2015 Feb; 13():7. PubMed ID: 25643602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CPMV-induced synthesis of hollow mesoporous SiO2 nanocapsules with excellent performance in drug delivery.
    Kumar K; Kumar Doddi S; Arunasree MK; Paik P
    Dalton Trans; 2015 Mar; 44(9):4308-17. PubMed ID: 25640798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemically reducible lipid bilayer coated mesoporous silica nanoparticles demonstrating controlled release and HeLa and normal mouse liver cell biocompatibility and cellular internalization.
    Roggers RA; Lin VS; Trewyn BG
    Mol Pharm; 2012 Sep; 9(9):2770-7. PubMed ID: 22738645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of mesoporous silica nanoparticles.
    Wu SH; Mou CY; Lin HP
    Chem Soc Rev; 2013 May; 42(9):3862-75. PubMed ID: 23403864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular protein delivery by hollow mesoporous silica capsules with a large surface hole.
    Lim JS; Lee K; Choi JN; Hwang YK; Yun MY; Kim HJ; Won YS; Kim SJ; Kwon H; Huh S
    Nanotechnology; 2012 Mar; 23(8):085101. PubMed ID: 22293239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-coated mesoporous silica nanoparticles for the controlled release of macromolecules.
    Bhattacharyya S; Wang H; Ducheyne P
    Acta Biomater; 2012 Sep; 8(9):3429-35. PubMed ID: 22688089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica nanoparticles: A multifunctional nano therapeutic system.
    Mai WX; Meng H
    Integr Biol (Camb); 2013 Jan; 5(1):19-28. PubMed ID: 23042147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery.
    Park HS; Kim CW; Lee HJ; Choi JH; Lee SG; Yun YP; Kwon IC; Lee SJ; Jeong SY; Lee SC
    Nanotechnology; 2010 Jun; 21(22):225101. PubMed ID: 20453291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles.
    Zhang J; Li X; Rosenholm JM; Gu HC
    J Colloid Interface Sci; 2011 Sep; 361(1):16-24. PubMed ID: 21689824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.
    Zhang Y; Zhi Z; Jiang T; Zhang J; Wang Z; Wang S
    J Control Release; 2010 Aug; 145(3):257-63. PubMed ID: 20450945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
    Yu M; Jambhrunkar S; Thorn P; Chen J; Gu W; Yu C
    Nanoscale; 2013 Jan; 5(1):178-83. PubMed ID: 23076766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.